These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10138706)

  • 1. Clinical and economic benefits of a clinical pharmacokinetic service: 1987 versus 1992 data.
    Destache CJ
    Med Interface; 1994 Nov; 7(11):84-6, 89-90. PubMed ID: 10138706
    [No Abstract]   [Full Text] [Related]  

  • 2. Benefits of clinical pharmacy services in a community hospital.
    Williams LE
    Hosp Pharm; 1993 Aug; 28(8):759-63, 766-7. PubMed ID: 10127576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serving patient needs while implementing cost effectiveness programs in health care administration.
    Tootelian DH
    Health Mark Q; 1994; 11(3-4):161-73. PubMed ID: 10137013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reimbursement for clinical pharmaceutical services in university hospitals.
    Sylvester KL
    Am J Hosp Pharm; 1982 Apr; 39(4):642-3. PubMed ID: 7081242
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-benefit analysis of clinical pharmacy services in a community hospital.
    Meisel S
    Hosp Pharm; 1985 Dec; 20(12):904-6. PubMed ID: 10311347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACCP: economic evaluations of clinical pharmacy services: 2001-2005.
    Perez A; Doloresco F; Hoffman JM; Meek PD; Touchette DR; Vermeulen LC; Schumock GT;
    Pharmacotherapy; 2009 Jan; 29(1):128. PubMed ID: 19113803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economics & the pharmacy.
    Souhrada L
    Hospitals; 1990 Oct; 64(19):52, 54, 56. PubMed ID: 2119336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacy: data for a cost-effectiveness evaluation.
    Sita MJ
    Cost Containment; 1982 May; 4(10):3-6. PubMed ID: 10309595
    [No Abstract]   [Full Text] [Related]  

  • 9. Health economics assessment study of teicoplanin versus vancomycin in Gram-positive infections.
    Portolés A; Palau E; Puerro M; Vargas E; Picazo JJ
    Rev Esp Quimioter; 2006 Mar; 19(1):65-75. PubMed ID: 16688294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy U.R. cuts costs, drug use.
    Mosier RL
    Hosp Peer Rev; 1979 May; 4(5):70-2. PubMed ID: 10308905
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjusting dosage intervals of intermittent intravenous ranitidine according to creatinine clearance: a cost-minimization analysis.
    Connelly JF
    Hosp Pharm; 1994 Nov; 29(11):992, 996-8, 1001. PubMed ID: 10138581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-CSF (Granulocyte Colony-Stimulating Factor): follow-up and use in a French University hospital.
    Furet I; Closson V; Madelaine I; Faure P
    Can J Hosp Pharm; 1995 Apr; 48(2):90-7. PubMed ID: 10142843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of clinical pharmacist intervention on tobramycin prescribing.
    Khanderia U
    Hosp Formul; 1986 Oct; 21(10):1049-50, 1055-6. PubMed ID: 10311722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of 'treatment equivalents' supplements generics in controlling pharmacy costs.
    Cost Containment; 1980 Feb; 2(3):1. PubMed ID: 10309092
    [No Abstract]   [Full Text] [Related]  

  • 15. Appropriate but not cost effective ceftazidime use in a university hospital.
    Colburn PA; Carver PA; Montgomery PA; Alaniz C; Chaffee BW; Amesbury BK
    Hosp Pharm; 1989 Nov; 24(11):911-6, 928. PubMed ID: 10313376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacy analyzes costs, savings of computer information system.
    Neal T
    Hospitals; 1981 Feb; 55(3):70-4. PubMed ID: 6778809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of gentamicin premixed admixtures: cost and clinical utility.
    Zarowitz BJ; Owen H; Popovich J; Pancorbo S
    Hosp Pharm; 1987 Mar; 22(3):257-60. PubMed ID: 10311980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacists can ensure quality at acceptable costs.
    Skaar DJ; Oki JC; Elenbaas RM
    Healthc Financ Manage; 1991 Dec; 45(12):90, 92. PubMed ID: 10145551
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic impact and clinical benefits of pharmacist involvement on surgical wards.
    Ariano RE; Demianczuk RH; Danzinger RG; Richard A; Milan H; Jamieson B
    Can J Hosp Pharm; 1995 Oct; 48(5):284-9. PubMed ID: 10152783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What strategies can be tried to keep costs of antibiotics and other high-priced drugs from becoming true budget busters?
    Jaramilla JP; Colombo J; Simon L
    Hosp Formul; 1994 Apr; 29(4):305-8. PubMed ID: 10133129
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.